|
公司基本資料信息
|
產(chǎn)品詳細(xì)說明
阿伐那非
中文同義詞: 4-[(3-氯-4-甲氧基芐基)氨基]-2-[2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲磺酰胺;阿瓦那非;阿伐那菲;4-[(3-氯-4-甲氧基芐基)氨基]-2-[2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲磺酰胺
英文名稱: Avanafil
英文同義詞: (S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine;4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;Avanafil;Avanafil (usan/inn);D03217;4-[[(3-Chloro-4-Methoxyphenyl)Methyl] aMino]-2-[(2S)-2-(hydroxyMethyl)-1-pyrrolidinyl]-N-(2-pyriMidinylMethyl)-5-pyriMidinecarboxaMide;4-((3-chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide;(S)-4-((3-Chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide
CAS號: 330784-47-9
分子式: C23H26ClN7O3
分子量: 483.95
熔點 150-152°C
密度 1.372
外觀:白色粉狀
用途:磷酸二酯酶抑制劑。用于治療男性勃起功能障礙(ED)。
含量:99%(HPLC)
質(zhì)量標(biāo)準(zhǔn):企標(biāo)
保質(zhì)期:24(月)
包裝:1kg/25kg;
中文同義詞: 4-[(3-氯-4-甲氧基芐基)氨基]-2-[2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲磺酰胺;阿瓦那非;阿伐那菲;4-[(3-氯-4-甲氧基芐基)氨基]-2-[2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲磺酰胺
英文名稱: Avanafil
英文同義詞: (S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine;4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;Avanafil;Avanafil (usan/inn);D03217;4-[[(3-Chloro-4-Methoxyphenyl)Methyl] aMino]-2-[(2S)-2-(hydroxyMethyl)-1-pyrrolidinyl]-N-(2-pyriMidinylMethyl)-5-pyriMidinecarboxaMide;4-((3-chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide;(S)-4-((3-Chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide
CAS號: 330784-47-9
分子式: C23H26ClN7O3
分子量: 483.95
熔點 150-152°C
密度 1.372
外觀:白色粉狀
用途:磷酸二酯酶抑制劑。用于治療男性勃起功能障礙(ED)。
含量:99%(HPLC)
質(zhì)量標(biāo)準(zhǔn):企標(biāo)
保質(zhì)期:24(月)
包裝:1kg/25kg;
共0條 [查看全部] 相關(guān)評論